Profile | GDS4284 / 236826_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 207.546 | 50 |
GSM687648 | Patient 402 control | 161.823 | 45 |
GSM687653 | Patient 403 control | 156.719 | 45 |
GSM687658 | Patient 404 control | 268.947 | 54 |
GSM687663 | Patient 411 control | 18.3826 | 10 |
GSM687668 | Patient 422 control | 51.7009 | 24 |
GSM687673 | Patient 424 control | 172.853 | 44 |
GSM687678 | Patient 425 control | 93.7774 | 32 |
GSM687683 | Patient 427 control | 353.505 | 56 |
GSM687688 | Patient 428 control | 78.4194 | 30 |
GSM687695 | Patient 441 control | 136.28 | 31 |
GSM687699 | Patient 443 control | 24.947 | 12 |
GSM687704 | Patient 444 control | 141.696 | 41 |
GSM687707 | Patient 448 control | 188.372 | 43 |
GSM687712 | Patient 449 control | 114.237 | 37 |
GSM687719 | Patient 450 control | 156.094 | 39 |
GSM687724 | Patient 451 control | 17.5983 | 8 |
GSM687728 | Patient 452 control | 215.739 | 49 |
GSM687646 | Patient 401 treated 24h | 282.897 | 54 |
GSM687649 | Patient 402 treated 24h | 66.8337 | 29 |
GSM687665 | Patient 411 treated 24h | 34.9559 | 17 |
GSM687651 | Patient 402 treated 4 weeks | 16.9125 | 10 |
GSM687667 | Patient 411 treated 4 weeks | 30.5499 | 16 |
GSM687670 | Patient 422 treated 24h | 112.257 | 35 |
GSM687671 | Patient 422 treated 4 weeks | 199.463 | 49 |
GSM687654 | Patient 403 treated 24h | 92.2328 | 35 |
GSM687675 | Patient 424 treated 24h | 164.446 | 42 |
GSM687685 | Patient 427 treated 24h | 389.056 | 59 |
GSM687656 | Patient 403 treated 4 weeks | 82.7932 | 33 |
GSM687677 | Patient 424 treated 4 weeks | 153.617 | 43 |
GSM687687 | Patient 427 treated 4 weeks | 226.971 | 52 |
GSM687692 | Patient 428 treated 4h | 193.311 | 47 |
GSM687716 | Patient 449 treated 4h | 112.389 | 37 |
GSM687722 | Patient 450 treated 4h | 140.267 | 38 |
GSM687680 | Patient 425 treated 24h | 150.719 | 43 |
GSM687690 | Patient 428 treated 24h | 191.021 | 48 |
GSM687700 | Patient 443 treated 24h | 194.573 | 40 |
GSM687705 | Patient 444 treated 24h | 114.7 | 39 |
GSM687714 | Patient 449 treated 24h | 93.7846 | 35 |
GSM687721 | Patient 450 treated 24h | 24.8798 | 11 |
GSM687682 | Patient 425 treated 4 weeks | 142.073 | 42 |
GSM687694 | Patient 428 treated 4 weeks | 185.924 | 49 |
GSM687702 | Patient 443 treated 4 weeks | 188.983 | 45 |
GSM687718 | Patient 449 treated 4 weeks | 132.003 | 40 |
GSM687723 | Patient 450 treated 4 weeks | 173.497 | 44 |
GSM687661 | Patient 404 treated 4h | 185.601 | 46 |
GSM687710 | Patient 448 treated 4h | 24.442 | 14 |
GSM687726 | Patient 451 treated 4h | 88.0197 | 29 |
GSM687730 | Patient 452 treated 4h | 198.383 | 33 |
GSM687660 | Patient 404 treated 24h | 47.842 | 18 |
GSM687697 | Patient 441 treated 24h | 217.533 | 44 |
GSM687709 | Patient 448 treated 24h | 129.025 | 37 |
GSM687725 | Patient 451 treated 24h | 74.4647 | 25 |
GSM687729 | Patient 452 treated 24h | 497.425 | 63 |
GSM687727 | Patient 451 treated 4 weeks | 120.895 | 34 |
GSM687731 | Patient 452 treated 4 weeks | 293.308 | 53 |